[Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C].
Zeuzem
S
S
Medizinische Klinik II, Johann-Wolfgang-Goethe-Universität, Frankfurt a.M. Zeuzem@em.uni-frankfurt.de
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016867:Immunocompromised Host / Q000187:drug effects; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D012008:Recurrence; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use*
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin
Interferon-alpha und Ribavirin: Fortschritte in der Therapie der chronischen Hepatitis C.